Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
H01AX Other anterior pituitary lobe hormones and analogues
H01AX01 Pegvisomant
D05394 Pegvisomant (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Hormonal Agents, Suppressant (Pituitary)
Pegvisomant
D05394 Pegvisomant (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
249 Miscellaneous
2499 Others
D05394 Pegvisomant (USAN/INN); Pegvisomant (genetical recombination) (JAN)
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
GHR
D05394 Pegvisomant (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D05394
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D05394
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D05394
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D05394
